Clinical trial Recruiting at 1 site Observational

Adapting and testing PEN-Plus in Zambian primary care

Official title: PEN-Plus Initiation Grant Opportunity: Domestication and Implementation of the PEN-Plus Clinical Model in the Zambian Health System

Run by Centre for Infectious Disease Research in Zambia · NCT07753681 · Data updated 2026-11-12

Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.

Quick facts

Study typeObservational
SexAll
Enrollment2084 (estimated)
SponsorCentre for Infectious Disease Research in Zambia
Academic / other
Locations1 site (Lusaka, Lusaka Province)
StatusRecruiting
StartedAugust 8, 2022
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2027
Registry record updatedAugust 7, 2026
Trial IDNCT07753681 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with chronic non-communicable diseases presenting at the participating first-level hospitals.

Probably not a fit

Patients who do not engage with follow-up or whose care needs fall outside the PEN-Plus scope may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project will adapt the WHO PEN-Plus package for non-communicable diseases to the Zambian health system using the Interactive Systems Framework. It will implement and monitor the approach at two first-level hospitals (peri-urban and rural) with inclusive stakeholder input and bi-annual reporting to a project advisory board. The study focuses on capacity building, local adaptation, and potential scaling up across Zambia to improve management of chronic NCDs. Data from routine hospital records will inform implementation progress and guide future scale-up efforts.

Why it matters

Potential benefit: If successful, patients may receive more standardized and accessible care for chronic NCDs at primary care facilities.

How similar studies have gone: Prior work with PEN-Plus and ISF-based implementation has shown promise in improving NCD management in primary care in similar settings, though results vary by context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Presenting with chronic NCDs

Exclusion Criteria:

* Refusing to be followed up prospectively for routine visits

Where it's running

  • Matero First Level Hospital
    Lusaka, Lusaka Province, Zambia
    Recruiting

Study contacts

  • Principal investigator: Fastone Mathew Goma, MB ChB — Centre for Infectious Disease Research in Zambia
  • Study coordinator: Bupe Sichalwe, ADULT EDUCATION
  • Email: bupe.sichalwe@cidrz.org
  • Phone: 977401513

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.